• S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

  • 2022/04/11
  • 再生時間: 23 分
  • ポッドキャスト

S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

  • サマリー

  • In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?

    Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

    続きを読む 一部表示

あらすじ・解説

In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?

Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

activate_samplebutton_t1

S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgradeに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。